新世界(00017.HK)推出捐贈配對網上平台「Share for Good 愛互送」
新世界發展(00017.HK)宣布,推出捐贈配對網上平台「Share for Good 愛互送」,促使捐助者和受助人迅速配對。集團與主要合作夥伴仁濟醫院及逾30間非牟利機構協助基層抗疫,並由即時送貨平台Lalamove提供物流支援。
「愛互送」平台不會收取行政費用,物流支出則由新世界及Lalamove共同承擔,而新世界已向平台捐出20萬件抗疫物資。
參與的非牟利機構及社企向其服務對象了解所需的抗疫用品後,整理出13項最為殷切的物資清;當網上平台配對到捐助者後,將盡快由各機構將有關物資分發給有需要人士。平台開放予全香港巿民參與,捐助者亦可選擇以現金捐款代購,由仁濟醫院統籌代購及派發服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.